Ticagrelor and Ferrous fumarate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ticagrelor (ticagrelor) and Ferrous fumarate (ferrous fumarate). Common drug interactions include agranulocytosis among females and cardiac arrest among males.

The phase IV clinical study analyzes what interactions people have when they take Ticagrelor and Ferrous fumarate. It is created by eHealthMe based on reports of 54 people who take the same drugs from the FDA, and is updated regularly.

What is Ticagrelor?

Ticagrelor has active ingredients of ticagrelor. eHealthMe is studying from 8,499 Ticagrelor users. Check the latest studies of Ticagrelor.

What is Ferrous fumarate?

Ferrous fumarate has active ingredients of ferrous fumarate. It is often used in anemia. eHealthMe is studying from 9,840 Ferrous fumarate users. Check the latest studies of Ferrous fumarate.

On Aug, 02, 2026

54 people who take Ticagrelor and Ferrous fumarate together, and have interactions are studied.

Ticagrelor and Ferrous fumarate drug interactions.

What are the common drug interactions of Ticagrelor and Ferrous Fumarate, by gender? *:

female:

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Death
Haemorrhage intracranial (bleeding within the skull)
Dizziness
Anal haemorrhage
Cardiac disorder
Dyspnoea (difficult or laboured respiration)
Nausea (feeling of having an urge to vomit)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Alopecia (absence of hair from areas of the body)

male:

Cardiac arrest
Gastritis (inflammation of stomach)
Anaemia (lack of blood)
Barrett's oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach)
Dizziness exertional
Duodenal ulcer
Faeces discoloured
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Hyperkalaemia (damage to or disease of the kidney)
Liver disorder (liver diseases)

What are the common drug interactions of Ticagrelor and Ferrous Fumarate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Alopecia (absence of hair from areas of the body)
Cardiac disorder
Dizziness
Drug ineffective
Dyspnoea (difficult or laboured respiration)
Finger deformity (a deformed position of the finger)
Hand deformity
Headache (pain in head)
Infarction (obstruction of the blood supply to an organ or region of tissue)

60+:

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Haemorrhage intracranial (bleeding within the skull)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
Loss of consciousness
Peripheral ischaemia (impaired circulation to an extremity)
Pulmonary alveolar haemorrhage (acute bleeding)
Pyrexia (fever)
Respiratory failure (inadequate gas exchange by the respiratory system)
Sudden death

What are the existing conditions these people have? *

Iron Deficiency: 12 people, 22.22%
Heart Attack: 11 people, 20.37%
Indigestion: 10 people, 18.52%
Acute Myocardial Infarction (acute heart attack): 6 people, 11.11%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 4 people, 7.41%
Urinary Tract Infection: 3 people, 5.56%
Constipation: 3 people, 5.56%
Cardiac Failure: 3 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Ticagrelor and Ferrous fumarate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously